Retro- and prospective, single-center study to evaluate the safety and effectiveness 3 years after the XEN 45 stent implantatio
Not Applicable
- Conditions
- H40.1H17Primary open-angle glaucomaCorneal scars and opacities
- Registration Number
- DRKS00023619
- Lead Sponsor
- Dietrich Bonhoeffer Klinikum, Klinik für Augenheilkunde
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Patients 2 to 5 years after implantation of a XEN 45 stent (2013-2018)
- Willingness of patients to participate in the study and written consent.
Exclusion Criteria
- Patients with a distant place of residence or with a limited general condition due to illness, who cannot be expected to travel to Neubrandenburg.
- Patients who have moved unknown.
- Deceased patients (existing data are documented).
- Patients who are not interested in participating in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determination of the effect of the XEN 45 microstent implantation on intraocular pressure, the number of necessary antiglaucomatous therapies, the progression of glaucoma in terms of visual field deterioration and progression of glaucomatous papillary changes and the loss of endothelial cells.
- Secondary Outcome Measures
Name Time Method Safety of the procedure based on the intra- and post-operative complications that have occurred.<br><br>Development of the stent-associated conjunctival filtering bleb,<br><br>Long-term success rate of the XEN 45 stent<br><br>Clinical identification of stent failure.